论文部分内容阅读
本刊讯日前,国家食品药品监督管理总局发布通告,要求所有药品经营、使用单位立即停止销售、使用海南益尔药业有限公司生产的氟哌噻吨美利曲辛片及盐酸氟哌噻吨、盐酸美利曲辛原料药。2015年底,国家食品药品监督管理总局组织海南省食品药品监督管理局对海南益尔药业有限公司开展飞行检查,发现其存在较严重的违法违规行为。经现场检查和产品抽检,发现海南益尔药业有限公司生产的3批盐酸氟哌噻吨(批号:
Recently, the State Food and Drug Administration issued a circular calling for all drugs to operate, the use of units immediately stop the sale, the use of Haier Pharmaceutical Co., Ltd. Haier production of flupentixol and melitracen tablets and flupenthixol hydrochloride , Melitracine hydrochloride API. At the end of 2015, the State Food and Drug Administration organized Hainan Food and Drug Administration to carry out flight inspection on Hainan Yier Pharmaceutical Co., Ltd. and found that there were serious violations of laws and regulations. After the on-site inspection and product sampling, found that Hainan Yier Pharmaceutical Co., Ltd. produced three batches of flupentixol hydrochloride (batch number: